Parker BS - Search Results

1

Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.

Sceneay J, Chow MT, Chen A, Halse HM, Wong CS, Andrews DM, Sloan EK, Parker BS, Bowtell DD, Smyth MJ, Möller A. Sceneay J, et al. Among authors: parker bs. Cancer Res. 2012 Aug 15;72(16):3906-11. doi: 10.1158/0008-5472.CAN-11-3873. Epub 2012 Jul 2. Cancer Res. 2012. PMID: 22751463

2

Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.

Eckhardt BL, Parker BS, van Laar RK, Restall CM, Natoli AL, Tavaria MD, Stanley KL, Sloan EK, Moseley JM, Anderson RL. Eckhardt BL, et al. Among authors: parker bs. Mol Cancer Res. 2005 Jan;3(1):1-13. Mol Cancer Res. 2005. PMID: 15671244

3

Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.

Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, George J, Slavin JL, Möller A, Steel R, Pouliot N, Eckhardt B, Henderson MA, Anderson RL. Parker BS, et al. J Pathol. 2008 Feb;214(3):337-46. doi: 10.1002/path.2265. J Pathol. 2008. PMID: 17985332

4

Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis.

Kusuma N, Denoyer D, Eble JA, Redvers RP, Parker BS, Pelzer R, Anderson RL, Pouliot N. Kusuma N, et al. Among authors: parker bs. Int J Cancer. 2012 Feb 1;130(3):555-66. doi: 10.1002/ijc.26018. Epub 2011 May 5. Int J Cancer. 2012. PMID: 21387294

5

Cathepsin B inhibition limits bone metastasis in breast cancer.

Withana NP, Blum G, Sameni M, Slaney C, Anbalagan A, Olive MB, Bidwell BN, Edgington L, Wang L, Moin K, Sloane BF, Anderson RL, Bogyo MS, Parker BS. Withana NP, et al. Among authors: parker bs. Cancer Res. 2012 Mar 1;72(5):1199-209. doi: 10.1158/0008-5472.CAN-11-2759. Epub 2012 Jan 19. Cancer Res. 2012. PMID: 22266111 Free PMC article.

6

Vascular normalization by loss of Siah2 results in increased chemotherapeutic efficacy.

Wong CS, Sceneay J, House CM, Halse HM, Liu MC, George J, Hunnam TC, Parker BS, Haviv I, Ronai Z, Cullinane C, Bowtell DD, Möller A. Wong CS, et al. Among authors: parker bs. Cancer Res. 2012 Apr 1;72(7):1694-704. doi: 10.1158/0008-5472.CAN-11-3310. Epub 2012 Feb 21. Cancer Res. 2012. PMID: 22354750

7

Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape.

Bidwell BN, Slaney CY, Withana NP, Forster S, Cao Y, Loi S, Andrews D, Mikeska T, Mangan NE, Samarajiwa SA, de Weerd NA, Gould J, Argani P, Möller A, Smyth MJ, Anderson RL, Hertzog PJ, Parker BS. Bidwell BN, et al. Among authors: parker bs. Nat Med. 2012 Aug;18(8):1224-31. doi: 10.1038/nm.2830. Epub 2012 Jul 22. Nat Med. 2012. PMID: 22820642

8

The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone.

Slaney CY, Möller A, Hertzog PJ, Parker BS. Slaney CY, et al. Among authors: parker bs. Oncoimmunology. 2013 Jan 1;2(1):e22339. doi: 10.4161/onci.22339. Oncoimmunology. 2013. PMID: 23482870 Free PMC article.

9

Hypoxia-driven immunosuppression contributes to the pre-metastatic niche.

Sceneay J, Parker BS, Smyth MJ, Möller A. Sceneay J, et al. Among authors: parker bs. Oncoimmunology. 2013 Jan 1;2(1):e22355. doi: 10.4161/onci.22355. Oncoimmunology. 2013. PMID: 23482904 Free PMC article.

10

The emerging role of immunosurveillance in dictating metastatic spread in breast cancer.

Slaney CY, Rautela J, Parker BS. Slaney CY, et al. Among authors: parker bs. Cancer Res. 2013 Oct 1;73(19):5852-7. doi: 10.1158/0008-5472.CAN-13-1642. Epub 2013 Sep 23. Cancer Res. 2013. PMID: 24062312 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters